Brickell Biotech Inc., a clinical stage pharmaceutical company, completed an $8.05 million offering consisting of common stock. Faegre Drinker represented Brickell Biotech in the offering.
July 2021
Brickell Biotech Completes $8.05M Common Stock Offering
United States - Colorado
Lead Contacts
